Owen McCarty/LinkedIn
May 17, 2026, 11:04
Owen McCarty: Few Insights and Implications from Recent Clinical Trials of FXI Inhibitors
Owen McCarty, Professor and Chair at Oregon Health and Science University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Advances in Therapy, adding:
”We summarized a few insights and implications from recent clinical trials of coagulation FXI inhibitors.”
Title: Factor XI Inhibitors in Atrial Fibrillation: Insights and Implications from Recent Trials
Authors: Rosemary B. Falama, Lisa R. Matsumoto, Marie E. Piatski, Lukas Seifer, Aditya Malhotra, Owen J. T. McCarty, Joseph J. Shatzel
Stay updated on all scientific advances with Hemostasis Today.
-
May 17, 2026, 10:55National Phlebotomist Week and the People Powering Patient Care – Northwell Health
-
May 17, 2026, 10:54Amanda Unsworth: Discovering Heart and Thrombosis Science at Be Curious
-
May 17, 2026, 10:50Urs Fischer: Could a Three-in-One Pill Improve Outcomes After Brain Bleeding
-
May 17, 2026, 10:50CAR T-Cell Therapy and Life-Changing Progress in Autoimmune Disease – UNC Health
-
May 17, 2026, 10:18Shashank Joshi: Improved Functional Recovery After Stroke With Adjunctive Alteplase
-
May 17, 2026, 06:26The Long-Term Organ-Specific Complications of Nonextremity Thrombosis in Children – JTH
-
May 17, 2026, 04:41Rob Maloney: Hemophilia of Georgia Exists to Build the Support System Around People Living with Bleeding Disorders
-
May 17, 2026, 04:36Purusotham Chippala: Hemineglect Is One of The Most Misunderstood Conditions After Stroke
-
May 17, 2026, 04:27Andreas Calatzis: The Limitations of Monitoring Unfractionated Heparin During ECMO